Literature DB >> 28699143

Glutaric Aciduria Type 1 and Acute Renal Failure: Case Report and Suggested Pathomechanisms.

Marcel du Moulin1, Bastian Thies1, Martin Blohm1, Jun Oh1, Markus J Kemper1, René Santer1, Chris Mühlhausen2.   

Abstract

Glutaric aciduria type 1 (GA1) is caused by deficiency of the mitochondrial matrix enzyme glutaryl-CoA dehydrogenase (GCDH), leading to accumulation of glutaric acid (GA) and 3-hydroxyglutaric acid (3OHGA) in tissues and body fluids. During catabolic crises, GA1 patients are prone to the development of striatal necrosis and a subsequent irreversible movement disorder during a time window of vulnerability in early infancy. Thus, GA1 had been considered a pure "cerebral organic aciduria" in the past. Single case reports have indicated the occurrence of acute renal dysfunction in children affected by GA1. In addition, growing evidence arises that GA1 patients may develop chronic renal failure during adulthood independent of the previous occurrence of encephalopathic crises. The underlying mechanisms are yet unknown. Here we report on a 3-year-old GA1 patient who died following the development of acute renal failure most likely due to haemolytic uraemic syndrome associated with a pneumococcal infection. We hypothesise that known GA1 pathomechanisms, namely the endothelial dysfunction mediated by 3OHGA, as well as the transporter mechanisms for the urinary excretion of GA and 3OHGA, are involved in the development of glomerular and tubular dysfunction, respectively, and may contribute to a pre-disposition of GA1 patients to renal disease. We recommend careful differential monitoring of glomerular and tubular renal function in GA1 patients.

Entities:  

Year:  2017        PMID: 28699143      PMCID: PMC5953902          DOI: 10.1007/8904_2017_44

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  16 in total

1.  Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I.

Authors:  Chris Mühlhausen; Nicola Ott; Fariba Chalajour; Derya Tilki; Folke Freudenberg; Mona Shahhossini; Joachim Thiem; Kurt Ullrich; Thomas Braulke; Süleyman Ergün
Journal:  Pediatr Res       Date:  2006-02       Impact factor: 3.756

Review 2.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

3.  Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.

Authors:  Sven W Sauer; Jürgen G Okun; Gert Fricker; Anne Mahringer; Ines Müller; Linda R Crnic; Chris Mühlhausen; Georg F Hoffmann; Friederike Hörster; Stephen I Goodman; Cary O Harding; David M Koeller; Stefan Kölker
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

4.  Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1.

Authors:  Bastian Thies; Catherine Meyer-Schwesinger; Jessica Lamp; Michaela Schweizer; David M Koeller; Kurt Ullrich; Thomas Braulke; Chris Mühlhausen
Journal:  Biochim Biophys Acta       Date:  2013-04-24

5.  Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life.

Authors:  A P Pöge; F Autschbach; H Korall; F K Trefz; E Mayatepek
Journal:  Acta Paediatr       Date:  1997-10       Impact factor: 2.299

6.  3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3.

Authors:  Franziska Stellmer; Britta Keyser; Birgitta C Burckhardt; Hermann Koepsell; Thomas Streichert; Markus Glatzel; Sabrina Jabs; Joachim Thiem; Wilhelm Herdering; David M Koeller; Stephen I Goodman; Zoltan Lukacs; Kurt Ullrich; Gerhard Burckhardt; Thomas Braulke; Chris Mühlhausen
Journal:  J Mol Med (Berl)       Date:  2007-03-14       Impact factor: 4.599

7.  Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1.

Authors:  Britta Keyser; Markus Glatzel; Franziska Stellmer; Bastian Kortmann; Zoltan Lukacs; Stefan Kölker; Sven W Sauer; Nicole Muschol; Wilhelm Herdering; Joachim Thiem; Stephen I Goodman; David M Koeller; Kurt Ullrich; Thomas Braulke; Chris Mühlhausen
Journal:  Biochim Biophys Acta       Date:  2008-02-29

Review 8.  Membrane translocation of glutaric acid and its derivatives.

Authors:  C Mühlhausen; B C Burckhardt; Y Hagos; G Burckhardt; B Keyser; Z Lukacs; K Ullrich; T Braulke
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

Review 9.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors:  Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

10.  Glutaric Aciduria type I and acute renal failure - Coincidence or causality?

Authors:  Ben Pode-Shakked; Dina Marek-Yagel; Marina Rubinshtein; Itai M Pessach; Gideon Paret; Alexander Volkov; Yair Anikster; Danny Lotan
Journal:  Mol Genet Metab Rep       Date:  2014-04-17
View more
  2 in total

Review 1.  Organic acidurias in adults: late complications and management.

Authors:  Ali Tunç Tuncel; Nikolas Boy; Marina A Morath; Friederike Hörster; Ulrike Mütze; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2018-01-15       Impact factor: 4.982

2.  The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study.

Authors:  E M Charlotte Märtner; Eva Thimm; Philipp Guder; Katharina A Schiergens; Frank Rutsch; Sylvia Roloff; Iris Marquardt; Anibh M Das; Peter Freisinger; Sarah C Grünert; Johannes Krämer; Matthias R Baumgartner; Skadi Beblo; Claudia Haase; Andrea Dieckmann; Martin Lindner; Andrea Näke; Georg F Hoffmann; Chris Mühlhausen; Magdalena Walter; Sven F Garbade; Esther M Maier; Stefan Kölker; Nikolas Boy
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.